SCM
TMCI icon

Sterling Capital Management’s Treace Medical Concepts TMCI Stock Holding History

Sterling Capital Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-310
Closed -$415 – 3416
2026
Q1 		$415 Hold
310
– – ﹤0.01% 3167
2025
Q4 		$760 Buy
310
+194
+167% +$842 ﹤0.01% 3161
2025
Q3 		$778 Buy
116
+2
+2% +$13 ﹤0.01% 3111
2025
Q2 		$670 Buy
114
+64
+128% +$417 ﹤0.01% 3119
2025
Q1 		$420 Hold
50
– – ﹤0.01% 2989
2024
Q4 		$372 Hold
50
– – ﹤0.01% 3067
2024
Q3 		$290 Buy
+50
New +$321 ﹤0.01% 3040

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Sterling Capital Management's TMCI Position: Q2 2026 in Review

Sterling Capital Management sold out of Treace Medical Concepts (TMCI) in Q2 2026, closing a stake of 310 shares — an estimated $415 sold.

Sterling Capital Management first reported a position in TMCI in Q3 2024 and held it in 7 quarters. The position peaked at $778 in Q3 2025. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Sterling Capital Management reported no remaining Treace Medical Concepts position as of Q2 2026 after selling out during the quarter.
  • Sterling Capital Management sold 310 Treace Medical Concepts shares in Q2 2026, an estimated $415.
  • Sterling Capital Management first reported a position in Treace Medical Concepts in Q3 2024 and held it in 7 quarters.
  • Sterling Capital Management's Treace Medical Concepts position peaked at $778 in Q3 2025.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.